Several studies have indicated that alterations in TGF␤ receptor expression or function may be involved Summary in some cancers. For example, in a subset of colon cancer cell lines that display high rates of microsatellite The MAD-related (MADR) family of proteins are esseninstability and in several TGF␤-resistant human gastric tial components in the signaling pathways of serine/ cancers, genetic changes in the type II receptor have threonine kinase receptors for the transforming been identified (Markowitz et al., 1995; Park et al., 1994) . growth factor ␤ (TGF␤) superfamily. We demonstrate However, since intracellular targets of the TGF␤ recepthat MADR2 is specifically regulated by TGF␤ and not tors are poorly understood, the importance of disrupting bone morphogenetic proteins. The gene for MADR2 TGF␤ signaling pathways in promoting tumorigenesis is was found to reside on chromosome 18q21, near unknown.
DPC4, another MADR protein implicated in pancreatic
Recently, MADs (mothers against dpp) and MADR cancer. Mutational analysis of MADR2 in sporadic tu-(MAD-related) proteins have been identified in a variety mors identified four missense mutations in colorectal of species as important components of the signal transcarcinomas, two of which display a loss of heterozyduction pathway that are required for serine/threonine gosity. Biochemical and functional analysis of three kinase receptor signaling ; Hoodless of these demonstrates that the mutations are inacti Liu et al., 1996; Newfeld et al., 1996 ; Savage vating. These findings suggest that MADR2 is a tumor Sekelsky et al., 1995; Thomsen, 1996 ; Wierssuppressor and that mutations acquired in colorectal dorff et al., 1996) . Drosophila MAD and the highly related carcinomas may function to disrupt TGF␤ signaling.
vertebrate MADR1 appear to be essential for signaling of DPP/BMP2 pathways and can specify bone morphoIntroduction genetic protein (BMP)-specific biological responses Hoodless et al., 1996; Newfeld et al., 1996; Thomsen, 1996; Wiersdorff et al., 1996) . MAD An important step in the development of malignant tumors may involve the loss of sensitivity to negative proteins, although highly conserved across species, do not contain any known structural motifs; thus, it is diffigrowth regulators. TGF␤, a potent natural antiproliferative agent, is believed to play an important role in supcult to predict their precise mode of action (reviewed by Massagué , 1996; Wrana and Attisano, 1996) . However, pressing tumorigenicity. Comparisons of human colon Alignment of the predicted amino acid sequences of human MADR1, MADR2, and DPC4. Residues conserved in all three sequences are boxed, and the MH1 and MH2 regions at the amino-and carboxyl-termini are indicated (MH1, solid overline; MH2, broken overline). Gaps introduced to maximize alignment are shown as dots, and the amino acid residues are numbered on the right.
MADR1 is rapidly and specifically phosphorylated by database of expressed sequence tags (Lennon et al., 1996) . A pair of nonoverlapping partial clones were iden-BMP2 and not TGF␤-induced pathways (Hoodless et al., 1996) . Furthermore, MADR1 redistributes from the tified that contained open reading frames that displayed similarity either to the amino-or the carboxyl-terminus cytoplasm to the nucleus upon induction of signaling, suggesting that MADs may have a nuclear function of MADR1. To obtain the full-length coding sequence, we designed primers encoding the predicted start and (Hoodless et al., 1996; Liu et al., 1996) and may act as transcriptional activators (Liu et al., 1996) . Recently, a stop codons for polymerase chain reaction (PCR) and used a human kidney cDNA library as template. A contigsearch for tumor suppressor genes implicated in pancreatic cancer led to the identification of the MADuous sequence of 1605 base pairs was obtained, which included an open reading frame of 467 amino acids related gene, DPC4 (Hahn et al., 1996a) . However, the signaling pathway in which DPC4 functions is unknown.
( Figure 1 ). The predicted protein is related to MAD and MADR1, and, thus, we have termed this protein MADR2. In this study, we demonstrate that MADR2 is rapidly phosphorylated by activation of TGF␤ signaling pathAn alignment of MADR2 with the other mammalian MAD-related molecules indicates that it is more closely ways. The gene for MADR2 maps close to DPC4 at 18q21, a region often deleted in human cancers (Vorelated to MADR1 than to DPC4, a candidate tumor suppressor gene in pancreatic cancer (Hahn et al., gelstein et al., 1988; Yamaguchi et al., 1992) . Analysis of MADR2 in sporadic colorectal carcinoma has identified 1996a). Further, MADR2 is highly related (98% identity) to the Xenopus homolog, XMad2 (data not shown; Graff four missense mutations in MADR2, two of which are associated with a loss of heterozygosity (LOH). Bioet al., 1996) . As described for MADR1, the highest degree of conservation between MADR2 and the other chemical analysis indicates that three of these missense mutations lead to either a loss of protein expression or MADs lies in the MH1 and MH2 domains (Figure 1 ). loss of TGF␤-regulated phosphorylation. Furthermore, functional analysis of mesoderm induction in Xenopus Phosphorylation of MADR2 by TGF␤ Signaling Pathways embryos demonstrates that these three mutations also lead to inactive protein. Thus, MADR2, a component of Since MADR1 functions in BMP2 signaling pathways and is regulated by phosphorylation (Hoodless et al., the TGF␤ signaling pathway, is functionally mutated in tumors and is implicated as a tumor suppressor gene 1996), we sought to determine which serine/threonine kinase receptor-activated pathways might regulate in colorectal carcinoma. Together with the suggested involvement of DPC4 in pancreatic cancer, these find-MADR2. To examine this, we utilized constitutively active type I serine/threonine kinase receptors. These type ings indicate that MADs may represent a new class of tumor suppressor genes important in human cancer.
I receptors, generated by the introduction of a charged residue in the highly conserved GS domain (Attisano et al., 1996; Hoodless et al., 1996; Wieser et al., 1995) , Results signal in the absence of ligand and type II receptors (Wieser et al., 1995) . To facilitate our analysis, we conIdentification of a MAD-Related Protein, MADR2 MAD and MAD-related proteins identified in Drosophila structed a mammalian expression vector that encoded a Flag epitope tag at the amino-terminus of MADR2 (MAD), Caenorhabditis elegans (sma-2, sma-3, sma-4), Xenopus (Xmad1 and Xmad2), and humans (MADR1, (FlagMADR2). To explore whether MADR2 was a target of TGF␤ or BMP signaling pathways, COS cells were DPC4) have been demonstrated to play a crucial role in signal transduction by members of the TGF␤ superfamtransiently transfected with FlagMADR2 alone or together with wild-type or activated T␤RI or ALK-3 (a BMP ily (reviewed by Massagué , 1996; Wrana and Attisano, 1996) . To clone a MAD-related molecule that might functype I receptor the GeneBridge 4 RH panel (Walter et al., 1994) , and the marker, D18S460, which we linked to MADR2 on the RH map (Hudson et al., 1995) , and further analysis of our YACs identified three clones that contained both Analysis of the immunoprecipitates revealed that phosphorylation of MADR2 was unaffected by the coexpres-MADR2 and D18S460 ( Figure 3 ). The cytogenetic position of MADR2 was confirmed further by fluorescence sion of wild-type T␤RI, wild-type ALK-3, or activated ALK-3 ( Figure 2 ). In contrast, MADR2 phosphorylation in situ hybridization mapping two gene-specific P1-derived artificial chromosome clones (66i18 and 201n19) was substantially increased in cells cotransfected with activated T␤R I. Tryptic phosphopeptides from this samto 18q21 (S. W. S., unpublished data). The observation that MADR2 mapped to chromosome ple yielded one major novel phosphopeptide, indicating that phosphorylation is specific (M. Macias-Silva, L. A., 18q21 prompted us to determine its relative location with respect to DPC4 and DCC, which also map to 18q21 and J. L. W., unpublished data). Immunoblotting with antiflag antibody of total cell lysates prepared in parallel (Hahn et al., 1996a) and have been shown to be frequently deleted in pancreatic cancer (Hahn et al., 1996a , confirmed that approximately equivalent amounts of MADR2 protein were examined (Figure 2 ). In a parallel 1996b) and colon cancer (Fearon et al., 1990; Vogelstein et al., 1988) , respectively. Accordingly, gene-specific analysis of MADR1, increased phosphorylation was detected only in cells cotransfected with constitutively acsequence-tagged sites (STSs) for DPC4 and DCC were tested against the RH panel and all of the YAC clones tive ALK-3, as shown previously (data not shown; Hoodless et al., 1996) . from the WC18.5 contig. Using the previously published YAC and RH map (Hudson et al., 1995) as a framework, To determine whether MADR2 phosphorylation was regulated in a TGF␤-dependent manner, we stably we could establish the following order: 18cen-MADR2-DPC4-DCC-18qter ( Figure 3 ). Both the YAC and RH data transfected mink lung (Mv1Lu) epithelial cell lines with FlagMADR2 under the control of an inducible-metallothifor the genes were in complete agreement. However, the precise physical distance separating the genes was onein promoter (Wrana et al., 1992) . Mv1Lu epithelial cells express both type I and type II receptors and are difficult to establish, since the map was based only on STS content and because two gaps are present within TGF␤-sensitive. Several independent pools of cells expressing FlagMADR2 in a zinc-inducible manner were the YAC contig ( Figure 3 ). Nevertheless, it was evident that MADR2 mapped to the same cytogenetic band as generated, and the regulation of MADR2 phosphorylation in response to TGF␤ was examined in two pools.
DPC4 and DCC and within close enough physical proximity to suggest that it may also be frequently deleted Analysis of MADR2 immunoprecipitated from [ 32 P]phosphate-labeled cells that were untreated or treated with in tumors demonstrating LOH of 18q21. Cho et al., 1994) along the chromosome, to be 18cen-5Ј-DCC-3Ј-18qter. MADR2 has been shown to map to 18q21 in this study, DPC4 maps to 18q21.1 (Hahn et al., 1996a) , and DCC maps to 18q21.3 (GenBank Database).
MADR2 Is Mutated in Colorectal Carcinoma
MADR2 was found to have wild-type sequence, indicating that these mutations were acquired as somatic The localization of MADR2 to 18q21 led us to investigate whether mutations in this gene might play a role in the events. These latter studies also served to demonstrate that MADR2 is expressed in normal human colorectal development of some forms of cancer. To explore this possibility, we examined a variety of human tumors for tissue. We also examined SSCP band intensities. Comparison of mutant and wild-type alleles in each tumor mutations in MADR2 using single-strand conformation polymorphism (SSCP) analysis of cDNA. We focused on sample showed that tumors 357 and 369 had little or no wild-type message, suggesting LOH at this locus. To the MH1 and MH2 domains of MADR2, which display the highest degree of similarity among members of the date, we have not found evidence for germline mutations of MADR2 in a panel of lymphoblastoid lines generated MAD family. Furthermore, it is within the MH2 domain that all of the identified mutations in DPC4 reside (Hahn from 15 patients who had a strong family history of colorectal tumors or who presented with colorectal canet al., 1996a). Our initial screen of 101 axillary nodenegative breast carcinomas and 76 sarcomas (which cer at a young age. Together, these data show that mutations in MADR2 are specifically associated with included 35 osteosarcomas) did not reveal any mutations, with the exception of a single benign polymorsporadic colorectal carcinoma and suggest that MADR2 is a candidate tumor suppressor at 18q21. phism at an arginine residue in one breast cancer sample (nucleotide 1245: A→G). However, in a screen of 66 sporadic colon carcinomas, we identified four tumors that had missense mutations in MADR2 (6%). In none MADR2 Containing Missense Mutations Are Not Regulated by TGF␤ of the samples did we detect any other neutral polymorphisms. For three of the mutations, alterations occurred Mutation of a conserved residue within the MH2 domain of MADR1 has been shown to disrupt regulation by the in highly conserved residues within the MH2 domain and involved two nonconservative (P445H and L440R) BMP2 signaling pathway and correlates with the loss of functional protein (Hoodless et al., 1996; Savage et al., and one conservative (D450E) change (Figure 4 ; Table  1 ). The fourth missense mutation mapped to the MH1 1996; Sekelsky et al., 1995) . To determine the potential consequences of the missense mutations we identified domain and resulted in the alteration of a highly conserved arginine residue to a cysteine (R133C; Figure 4 ; in the MH2 domain of MADR2, we investigated the regulation of the mutant proteins by the TGF␤ signaling path- Table 1 ). In the three cases in which adjacent normal colorectal tissue was available (213, 357, and 348), way. To test this, we introduced the mutations L440R, 
Mesoderm Induction Assays
Xenopus blastula stage ectoderm can differentiate into mesodermal tissues in response to particular members P445H, and D450E into wild-type FlagMADR2 and expressed the protein in COS-1 cells together with either of the TGF␤ superfamily (reviewed by Kessler and Melton, 1994; Wall and Hogan, 1994) . For example, BMPs wild-type or constitutively active T␤RI. Relative phosphorylation levels were assessed by immunoprecipitainduce ventral mesoderm such as blood, whereas activin induces dorsal types of mesoderm such as muscle tion of MADR2 protein from [ 32 P]phosphate-labeled cells and quantitating protein levels by Western blotting of and notochord. Similar to the common biological responses observed for activin and TGF␤ in mammalian whole-cell lysates. When wild-type MADR2 was coexpressed with activated T␤RI, typical elevations in phoscells (Cá rcamo et al., 1994) , TGF␤ can also induce dorsal mesoderm in caps ectopically expressing TGF␤ type II phorylation of MADR2 were observed ( Figure 5 ). In contrast, two of the MADR2 mutants, 213 and 357 (P445H receptor (Bhushan et al., 1994) . Further, overexpression of a Xenopus homolog of T␤RI that is 98% identical to and D450E, respectively), showed no alterations in relative phosphorylation upon coexpression with activated T␤RI in the kinase domain similarly results in formation of dorsal mesoderm (Mahony and Gurdon, 1995) . Interreceptors. Thus, both the nonconservative P445H and the conservative D450E mutations disrupt the regulation estingly, overexpression of the Xenopus MAD-related proteins, XMad1 and XMad2, in the ectoderm mimics of MADR2 phosphorylation. In several attempts to express the 369 mutant (L440R) in COS cells, we were these effects. Thus, XMad1 (or XMad) induces ventral Thomsen, 1996) . Since the protein sequence of human MADR2 is 98% identical to XMad2 (data not shown), we examined the effect of MADR2 expression in Xenopus embryos. MADR2 could induce mesoderm and trigger morphogenetic movements in a fashion similar to that of XMad2 (Figure 6 ). Expression of MADR2 from microinjected mRNA caused Xenopus ectoderm explants, or animal caps, to elongate ( Figure 6A ), as observed when T␤RII-expressing caps are treated with TGF␤ (Bhushan et al., 1994) . These shape changes are considered to reflect the cellular movements that normally occur in the dorsal embryonic mesoderm during gastrula and neurula stages. MADR2 could also trigger ectopic gastrulation movements in the ectoderm of intact embryos ( Figure  6A ) precisely at the time that normal gastrulation movements began on the dorsal side of the embryo in the Spemann organizer. The MADR2 mutants 213, 357, and 369, however, did not cause animal caps to elongate or produce ectopic gastrulation movements in embryos, suggesting that the mutant proteins are functionally inactive.
We also tested wild-type and mutant MADR2 proteins for their capacity to induce mesoderm in animal caps. Wild-type MADR2 induced strong expression of the general mesodermal marker gene, brachyury (Xbra; Smith et al., 1991) , but the mutants did not ( Figure 6B ). The lack of activity observed for the MADR2 mutants was not due to a lack of protein expression. Western blot analysis of MADR2 protein expression in injected animal caps showed that wild-type and mutant MADR2 were produced at nearly equal levels, except for 369, which was expressed at lower levels consistent with its apparent instability in mammalian tissue culture cells. These observations demonstrate that the mutations detected in colorectal tumors disrupt regulation by the TGF␤ sig- Wrana and Attisano, 1996) . In this study, we report the Spemann organizer, the normal site of gastrulation initiation. The characterization of MADR2 as an intracellular componormal gastrulation furrow (black arrow) of the embryo pictured here nent of the TGF␤ signaling pathway. We show that it is displaced from its usual more vegetal position, because of the maps to a tumor suppressor locus at 18q21 and that action of the ectopic furrow. All wild-type MADR2-injected embryos the gene is mutated in approximately 6% of sporadic displayed the phenotype shown (for all sets of embryos, n > 12). The embryos analyzed were siblings of those used in the animal colorectal carcinomas. We demonstrate that these mucap assays in (B), all of which expressed MADR2 proteins.
tations disrupt either the regulation of MADR2 by TGF␤ (B) RT-PCR analysis on animal caps injected with wild-type and mutated MADR2 mRNAs show that only wild-type, and not mutated, MADR2 induces mesoderm as scored by the expression of brachyury, a general mesoderm marker at early to mid-gastrulation. Caps body is shown in the lower panel. The Western blot confirms that were injected with control (C; pGEM vector transcripts) and wildthe various MADR2 proteins were synthesized in each set of caps, type or mutant MADR2 mRNAs as indicated. EF1-␣ expression was although mutant 369 displayed a lower level of expression. Animal scored as a general marker for RNA recovery. The emb RT plus and caps (10) were pooled for each sample analyzed by Western blot, minus lanes are positive and negative controls, using total embryand two cap equivalents were loaded per lane. Approximately 24 onic RNA that was (ϩ) or was not (Ϫ) reverse-transcribed. A Western caps were cut at late blastula (stage 8); at mid-gastrula (stage 12), blot of animal cap proteins stained with an anti-Flag antihalf were harvested for RT-PCR and half for protein analysis.
signaling pathways or the stable expression of the pronot determined whether this is due to a defect in translation or stability of the protein product, this mutation may tein. Furthermore, using a Xenopus model system, we show that these mutations lead to inactivation of MADR2 result in loss of MADR2 expression in target cells. In contrast, two of the mutations in the MH2 domain charprotein function.
acterized from tumors disrupt the regulation of MADR2 phosphorylation by TGF␤ signaling pathways. Studies MADR2 Functions in the TGF␤ Signaling Pathway on MADR1 have previously identified a mutation within Genetic studies in Drosophila and C. elegans have demthe MH2 domain that blocks phosphorylation by the onstrated that MADs are required for signaling by recep-BMP signaling pathways (Hoodless et al., 1996) . This tors for the TGF␤ superfamily (Hoodless et al., 1996;  particular mutation generates null phenotypes in Dro- Newfeld et al., 1996; Savage et al., 1996; Wiersdorff et sophila or C. elegans, providing evidence that these al., 1996). MADR1 has been shown previously to be types of mutations yield nonfunctional protein products specifically regulated by BMPs (Hoodless et al., 1996) , (Savage et al., 1996; Sekelsky et al., 1995) . We also and in this study, we show that MADR2 is regulated by observed similar inactivation of MADR2 protein function TGF␤ signaling pathways. These results demonstrate in Xenopus embryonic assays. Wild-type MADR2 inthat at least in the case of MADR1 and MADR2, these duces mesoderm and morphogenetic movements simimolecules lie in specific serine/threonine kinase receplar to that seen with Xenopus Mad2, and these activities tor signaling pathways. Studies in Xenopus further highare abolished for mutant MADR2 proteins. These findlight this specificity, since overexpression of specific ings suggest that alterations within the MH2 domain of MADs can recapitulate the biological response normally MADRs can disrupt regulation of phosphorylation and induced by activation of the upstream receptors. Hence, indicate that phosphorylation is important for MADR XMad1 signals BMP-like responses, while XMad2/ function. MADR2 signals TGF␤/activin-like responses (this study; Graff et al., 1996; Thomsen, 1996) . Thus, MADs play a central role in determining cellular responses to TGF␤-Disruption of MADR2 and TGF␤ Signaling like factors, and mutations that disrupt MADR2 function in Tumorigenesis are likely to result in specific defects in TGF␤ signaling.
Regardless of the mechanism, the MADR2 mutations we have identified in colorectal carcinoma yield nonfunctional protein. Thus, these mutations should lead MADR2 Is a Tumor Suppressor to a similar loss of activity in the developing tumors. Tumor suppressor genes are often inactivated when one This might lead to a disruption of TGF␤ signaling and allele acquires a somatic mutation and the second allele thereby result in a loss of TGF␤ sensitivity in the target is lost, typically through deletion (Cavenee et al., 1983) .
cells. Since TGF␤ is a potent antiproliferative factor for LOH at 18q21 has been identified in numerous human a broad range of epithelial cells, mutations in signaling cancers (Vogelstein et al., 1988; Yamaguchi et al., 1992) .
components of this pathway may thus allow tumor cells We mapped MADR2 to this region of the human genome, to escape this regulation. This would clearly give neoraising the possibility that MADR2 acts as a tumor supplastic clones a growth advantage in the tissue. Thus, pressor. Our random screen of 76 sarcomas, 101 breast loss of MADR2 function may make a major contribution carcinomas, and 66 sporadic colorectal carcinomas to the development of cancer. identified four mutations specific to colon carcinoma, of which at least three were acquired somatically. In two of the samples, we could clearly detect wild-type 18q21 Is a Locus for Multiple Tumor MADR2. Since this may be due to the presence of normal Suppressor Genes tissue in the specimen or to tumor heterogeneity, this LOH at 18q21 is frequently detected in many human precluded a determination of potential LOH in these cancers (Fearon et al., 1990; Vogelstein et al., 1988 ; individuals. Nonetheless, in two of our cases, there was Yamaguchi et al., 1992) . Interestingly, DPC4, another very low expression or loss of the normal allele sugges-MAD-related gene, has also been mapped to 18q21 in tive of an LOH of MADR2. Together with the observation close proximity to MADR2 and has been identified as a that these mutations are inactivating, these results procandidate tumor suppressor in pancreatic carcinoma vide strong evidence that MADR2 is a tumor suppressor (Hahn et al., 1996a) . A similar situation exists for adenogene in sporadic colorectal cancers. Recently, Riggins matous polyposis coli and mutated-in-colon cancer on et al. (1996) also reported the presence of a genetic chromosome 5q21 (Joslyn et al., 1991; Kinzler et al. , alteration in a colorectal tumor of a gene, JV18-1, which 1991). Adenomatous polyposis coli mutations contribis likely to be the same as MADR2 described here.
ute to the development of sporadic and familial colorectal cancers; and both adenomatous polyposis coli and mutated-in-colon cancer are located in close physiMissense Mutations in MADR2 Are Functionally Disrupted cal proximity, share significant sequence homology with coiled-coil class proteins and are frequently deleted Our analyses of the regulation of MADR2 by TGF␤ signaling pathways demonstrate that the somatic mutaconcurrently in many different cancers. It is interesting to speculate on the functional relationship between DPC4 tions we have characterized can lead to two distinct defects. Characterization of the nonconservative L440R and MADR2. DPC4 may function downstream of a different TGF␤ superfamily member whose function is impormutation revealed that this change results in a defect in stable expression of MADR2 protein both in mammalian tant in controlling the growth of pancreatic cells. However, it is also possible that DPC4 might also function epithelial cells and in Xenopus embryos. While we have forw. 5Ј-ACCAATCAAGTCCCATGAAA-3Ј; rev. 5Ј TGATCGAGACCT in the TGF␤ signaling pathway, as suggested recently CAAGTGCTG-3Ј; DPC4. UTR: forw. 5Ј ATTGAAATTCACTTACACC for the multiple sma genes in BMP signaling in C. elegans GGG-3Ј; rev. 5Ј-AGCCATGCCTGACAAGTTCT-3Ј. The primers DCC. (Savage et al., 1996) . If the latter is the case, it raises PCR2.1/2.2 and DCC. PCR36.1/36.2, which are specific for the most the possibility that MADR2 and DPC4 together may 5Ј and 3Ј exons, respectively, of DCC, are described in the GenBank function in a cooperative way and that mutations in Database. Information on all of the other primers shown in Figureannealing for 40 s at 55ЊC, and extension for 40 s at 72ЊC, 35 cycles. RH mapping experiments were carried out in duplicate using the
Experimental Procedures
Genebridge 4 panel (Walter et al., 1994 ; purchased from Research Genetics). The Whitehead Institute-MIT Center for Genome ReConstruction of Expression Vectors search RH server was used to order the new STSs relative to frameSeveral clones displaying similarity to MADR1 (clone ID numbers work markers. All of the protocols used for YAC manipulations have 136422, 145032, and 138604) were identified from the expressed been described previously (Scherer and Tsui, 1991) . MADR2 desequence database (I.M.A.G.E.; Lennon et al., 1996) 1: 5Ј-AGATCAGTGGGATACAACAGG-3Ј and 5Ј-GGCACTAATACTG For the generation of stable transfectants, FlagMADR2 was sub-GAGGCAA-3Ј (264 bp); Region 2: 5Ј-AGCTTGGATTTACAGCC cloned into pMEP4 (Invitrogen) behind a metallothionein-inducible AGT-3Ј and 5Ј-TAAGCGCACTCCTCTTCCTA-3Ј (237 bp); Region 3: promoter using convenient sites in the vector polylinker (Wrana et 5Ј-GGCTCAGTCTGTTAATCAGG-3Ј and 5Ј-TTCCATGGGACTTGAT al., 1992) .
TGGT-3Ј (249 bp); Region 4: 5Ј-TGTTAACCGAAATGCCACGG-3Ј and 5Ј-TCTTATGGTGCACATTCTAGT-3Ј (293 bp). Regions 1 and 2 were Cell Lines and Transfections amplified simultaneously in the same reaction tube. Cycling condi-COS-1 cells were maintained and transfected using the diethylamitions involved 35 cycles at 94ЊC for 15 s, 55ЊC for 15 s, and 72ЊC noethyl-dextran as described (Hoodless et al., 1996) . The Mv1Lu for 20 s, using the 9600 Thermocycler (Perkin-Elmer). PCR product mink lung cells (CCL-64) expressing FlagMADR2 in pMEP4 (Inwas mixed with 2 vol of denaturing dye (95% formamide, 20 mM vitrogen) were generated by transfection with lipofectin (Gibco/BRL) EDTA, 0.05% Bromophenol Blue, and 0.05% Xylene Cyanol FF), as described previously (Wrana et al., 1992) . Pools of cell colonies heat-denatured, and loaded on an SSCP gel (8% acrylamide: were maintained in the continuous presence of hygromycin. Flagbis-acrylamide [40:1], 0.5 ϫ Tris-borate-EDTA, and 10% glycerol). MADR2 expression was induced by the overnight incubation of cells Electrophoresis was carried out at 16ЊC using a StrataTherm Cold in medium containing 0.2% serum and 50 M ZnCl 2.
temperature-controlled apparatus (Stratagene). Mutations were confirmed by direct sequencing of asymmetric PCR products.
Immunoprecipitations and Immunoblotting
Stably or transiently transfected cells were labeled for 2 hr with Xenopus Embryonic Assays [ 32 P]phosphate as described previously (Attisano et al., 1996;  The cDNAs for MADR2 and its mutant forms were subcloned into Wrana et al., 1994) . For stable cell lines, Zn 2ϩ -induced monolayers the CS2ϩ vector (Rupp et al., 1994) , and plasmids were linearized were incubated in the presence or absence of 100 pM TGF␤ (R with NotI prior to SP6 transcription of capped synthetic mRNA (using and D Systems) in the last 15 min of the phosphate labeling. Cell the mMessage Machine kit, Ambion Inc.). Transcripts from a linearlysates were subjected to immunoprecipitation with anti-Flag M2 ized vector (pGEM 7) served as a negative control for mRNA injecmonoclonal antibody (IBI, Eastman Kodak), followed by adsorption tion. Each mRNA (1.0 ng) was injected into the animal pole of a twoto protein G-sepharose (Pharmacia). Immunoprecipitates were cell blastula (0.5 ng per blastomere), and animal caps were excised washed, separated by SDS-polyacrylamide gel electrophoresis at blastula stage 8 and cultured in vitro, or the embryos were allowed (SDS-PAGE), and visualized by autoradiography. For determination to develop intact to assay ectopic gastrulation movements. Proteins of MADR2 protein levels, lysates were prepared from cells treated for Western blots were prepared by lysing animal caps (10 caps per in parallel with those subjected to in vivo phosphate labeling. Pro-100 l) directly in 2 ϫ Laemmli gel loading buffer. RNA was prepared teins from cell lysates were separated by SDS-PAGE and transferred from animal caps and reverse transcriptase-PCR (RT-PCR) perto nitrocellulose membranes. FlagMADR1 was detected using antiformed as described (Thomsen, 1996; Wilson and Melton, 1994 ) FLAG M2 antibody (1:3000 dilution) and chemiluminesence as recusing a 25 l reaction volume. A fraction (one-half) of a cap or 0.2 ommended by the manufacturer (ECL Kit, Amersham). embryo equivalents were analyzed by RT-PCR, using 17 cycles of amplification for Ef1-␣ and 24 cycles for XBra. A fraction (one-fifth) of each sample was loaded on a 6% PAGE (0.5 ϫ Tris-borate-EDTA) RH and YAC Contig Mapping The following PCR primers specific for the 3Ј-UTR of MADR2 and gel. Film (Kodak XAR) was exposed for 3 hr to detect Ef1-␣ and the embryo RT plus and minus lanes of Xbra. Xbra signals from animal DPC4 were designed using the Primer Version 3.0 program (Whitehead Institute-MIT Center for Genome Research): MADR2: caps were exposed for 6 hr.
